Suppr超能文献

基于 UPLC-Q-TOF-MS 的代谢组学研究芍药甘草汤对葡聚糖硫酸钠诱导的结肠炎小鼠近端和远端结肠的影响

Metabolomics Study of Shaoyao Plants Decoction on the Proximal and Distal Colon in Mice with Dextran Sulfate Sodium-Induced Colitis by UPLC-Q-TOF-MS.

机构信息

The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.

Academic Affairs Office, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.

出版信息

Drug Des Devel Ther. 2022 Dec 22;16:4343-4364. doi: 10.2147/DDDT.S384607. eCollection 2022.

Abstract

PURPOSE

Shaoyao decoction (SYD) is a traditional Chinese medicine used to treat ulcerative colitis (UC). The exact mechanism of action of SYD in UC treatment is still unclear. Here, we examined the therapeutic effects of SYD in mice with dextran sulfate sodium (DSS)-induced colitis and explored the underlying mechanism.

METHODS

The experimental group was divided into normal control, UC, and SYD treatment groups. The UC model of C57BL/6 mice was induced using 3% (w/v) DSS for 7 days. SYD was orally administered for 7 days. The proximal and distal colonic metabolic profiles were detected using quadrupole-time-of-flight mass spectrometry-based untargeted metabolomics.

RESULTS

SYD significantly increased weight, reduced disease activity index scores, and ameliorated colon length shortening and pathological damage in mice. In the distal colon, SYD increased the abundance of phosphatidic acid and lysophosphatidylethanolamine and decreased the abundance of lactosylceramide, erythrodiol 3-palmitate, and lysophosphatidylcholine. In the proximal colon, SYD increased the abundance of palmitic acid, cyclonormammein, monoacylglyceride, 13S-hydroxyoctadecadienoic acid, and ceanothine C and decreased the abundance of tetracosahexaenoic acid, phosphatidylserine, and diglyceride.

CONCLUSION

Our findings revealed that SYD could alleviate UC by regulating metabolic dysfunction, which provides a reference for further studies on SYD.

摘要

目的

芍药汤(SYD)是一种用于治疗溃疡性结肠炎(UC)的中药。SYD 在 UC 治疗中的确切作用机制尚不清楚。在这里,我们研究了 SYD 在葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠中的治疗效果,并探讨了其潜在的机制。

方法

实验组分为正常对照组、UC 组和 SYD 治疗组。通过给予 3%(w/v)DSS 7 天诱导 C57BL/6 小鼠 UC 模型。SYD 经口给药 7 天。使用基于四极杆-飞行时间质谱的非靶向代谢组学检测近端和远端结肠的代谢谱。

结果

SYD 显著增加了小鼠的体重,降低了疾病活动指数评分,并改善了结肠长度缩短和病理损伤。在远端结肠,SYD 增加了磷脂酸和溶血磷脂酰乙醇胺的丰度,降低了乳酰基神经酰胺、赤式-3-棕榈酸酯和溶血磷脂酰胆碱的丰度。在近端结肠,SYD 增加了棕榈酸、环诺马米嗪、单酰基甘油、13S-羟基十八碳二烯酸和长春碱 C 的丰度,降低了二十四碳六烯酸、磷脂酰丝氨酸和二甘油酯的丰度。

结论

我们的研究结果表明,SYD 可以通过调节代谢功能障碍来缓解 UC,这为进一步研究 SYD 提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f4d/9792814/d6dd0280afd2/DDDT-16-4343-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验